Our Pricing

Promethazine BNF Clinical Checklist Guide

This promethazine BNF clinical guidance UK resource provides healthcare professionals and patients with evidence-based prescribing information aligned with British National Formulary standards. At Cured Pharmacy, our UK-registered clinical team applies these protocols to every promethazine consultation, ensuring safe, appropriate prescribing of Phenergan products from £17.54.

Promethazine Hydrochloride: BNF Classification and Mechanism

Promethazine hydrochloride is classified in the BNF as a sedating antihistamine with antiemetic, antiallergic, and sedative properties [1]. As a phenothiazine derivative, it competitively blocks histamine H1 receptors in the central nervous system and peripheral tissues, preventing histamine-mediated allergic responses whilst producing dose-dependent sedation.

The medication's anticholinergic activity contributes to its antiemetic effects by blocking muscarinic receptors in the vomiting centre and vestibular apparatus [1]. This dual mechanism makes promethazine particularly effective for motion sickness, allergic conditions, and short-term insomnia, though the sedative properties necessitate careful patient counselling about next-day impairment.

BNF-Aligned Dosing Protocols for Promethazine

Adult dosing varies significantly by indication according to BNF guidance. For allergic conditions, the standard dose is 25mg at night, or 10-20mg two to three times daily if daytime administration is required [2]. Motion sickness prophylaxis requires 25mg the night before travel, followed by 25mg on the day of travel if necessary, taken at least 1-2 hours before departure.

For short-term insomnia management, BNF recommends 25-50mg at bedtime, though this indication is restricted to occasional use only (maximum 7 consecutive nights) due to tolerance development and next-day sedation risks [2]. Elderly patients require dose reduction due to increased sensitivity to anticholinergic effects and prolonged elimination half-life.

Paediatric Dosing Considerations

Promethazine is contraindicated in children under 2 years due to fatal respiratory depression risk [2]. For children aged 2-5 years, the maximum dose is 5-15mg daily in divided doses. Children 5-10 years may receive up to 25mg daily, whilst those over 10 years follow adult dosing schedules. Phenergan Elixir (5mg/5ml) facilitates accurate paediatric dosing and is available at Cured Pharmacy from £17.54 following clinical assessment.

Critical Contraindications and BNF Safety Warnings

The BNF lists absolute contraindications including children under 2 years, comatose states, concurrent monoamine oxidase inhibitor therapy, and known hypersensitivity to phenothiazines [3]. Promethazine must not be used within 14 days of MAOI discontinuation due to severe hypertensive crisis risk.

Relative contraindications requiring specialist assessment include severe coronary artery disease, epilepsy (lowers seizure threshold), prostatic hypertrophy, angle-closure glaucoma, pyloroduodenal obstruction, and hepatic impairment [3]. The MHRA issued specific warnings regarding respiratory depression risk in children, leading to the age 2 restriction and contraindication in any child with respiratory compromise.

Drug Interactions: BNF Clinical Checklist

Promethazine exhibits significant pharmacodynamic interactions with central nervous system depressants. Concurrent use with alcohol, benzodiazepines, opioids, or other sedating antihistamines produces additive sedation and respiratory depression [4]. Patients must be explicitly counselled to avoid alcohol throughout treatment.

Anticholinergic medication combinations (tricyclic antidepressants, antimuscarinics for overactive bladder, certain antipsychotics) increase risk of urinary retention, constipation, confusion, and heat stroke, particularly in elderly patients [4]. The BNF advises caution with medications prolonging QT interval, as promethazine may contribute to arrhythmia risk in susceptible individuals.

Pharmacokinetic Interaction Considerations

As a CYP2D6 substrate, promethazine metabolism may be affected by strong CYP2D6 inhibitors (fluoxetine, paroxetine, quinidine), potentially increasing plasma concentrations and adverse effect risk [4]. Poor CYP2D6 metabolisers experience prolonged elimination and enhanced sedation, though routine genotyping is not standard UK practice for promethazine prescribing.

Adverse Effects Profile and Patient Monitoring

The most common adverse effects align with promethazine's pharmacological profile: drowsiness (reported in up to 50% of patients), anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation), and paradoxical CNS stimulation in children [1][3]. Next-day sedation significantly impairs driving ability and skilled task performance, persisting up to 12 hours post-dose.

Serious but rare adverse effects include blood dyscrasias (agranulocytosis, thrombocytopenia), photosensitivity reactions, cholestatic jaundice, and extrapyramidal effects at higher doses [3]. The MHRA advises patients to report unexplained bruising, sore throat, fever, or jaundice immediately. Tolerance to sedative effects typically develops within 3-7 days, explaining the BNF restriction on prolonged insomnia use.

Promethazine Products Available at Cured Pharmacy

Cured Pharmacy dispenses three licensed promethazine formulations following UK prescriber assessment. Phenergan 25mg Tablets (56-tablet pack from £17.54) provide the standard adult dose for allergic conditions and motion sickness prophylaxis. Phenergan Night Tablets 25mg (smaller 14-tablet pack from £17.54) are specifically licensed for short-term insomnia management.

Phenergan Elixir (from £17.54) contains promethazine hydrochloride 5mg per 5ml, facilitating flexible paediatric dosing and offering an alternative for patients with dysphagia. All products require completion of a free online clinical consultation under 3 minutes with our UK-registered prescribers, ensuring BNF-compliant assessment of contraindications, interactions, and appropriateness. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical protocols at our GPhC-registered pharmacy (9012511).

Clinical Assessment Process

Our UK prescribers evaluate each promethazine request against BNF criteria, screening for contraindications, assessing concurrent medications for interaction risk, and confirming appropriate indication. Patients receive clear counselling on sedation risks, driving restrictions, and duration limits. Transparent pricing is displayed before consultation, with no hidden fees or subscription requirements.

Scientific References

1. Joint Formulary Committee. (2024). British National Formulary (BNF) 87. London: BMJ Group and Pharmaceutical Press. Promethazine hydrochloride monograph.
2. National Institute for Health and Care Excellence. (2023). Promethazine hydrochloride: Prescribing information. NICE British National Formulary.
3. Medicines and Healthcare products Regulatory Agency. (2019). Promethazine hydrochloride: Reminder of contraindication in children under 2 years and those with respiratory conditions. Drug Safety Update, 12(8), A1.
4. Stockley, I. H. (2023). Stockley's Drug Interactions (13th ed.). London: Pharmaceutical Press. Antihistamines, sedating: Interactions monograph.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.